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Identity 
Hugo: CARD8 
Other names: CARDINAL; DACAR; 
DKFZp779L0366; KIAA0955; MGC57162; NDPP1; 
TUCAN 
Location: 19q13.32 
DNA/RNA 
Description 
The CARD8 gene contains 13 exons spanning over 
approximately 30 kb of genomic DNA. 
Transcription 
At least 5 transcripts have been identified generated by 
alternative splicing that together with different start 
codon usage yield different CARD8 isoforms. Gene 
products encoded by exons 1 to 13 and 5 to 13 yield 
TUCAN/CARD8-54-kDa and TUCAN/CARD8-48-
kDa, respectively. 
Protein 
Description 
The CARD8 gene encodes different CARD8 isoforms  
that contain the caspase-associated recruitment domain 
(CARD) in their carboxy-termini that acts as a protein-
protein interaction interface. A 431 amino acids 
CARD8 protein of 48-kDa (TUCAN-48) has been best 
studied and more recently a 54-kDa isoform (TUCAN-
54, 487 amino acids) was identified sharing the same 
CARD motif but with a different stretch of 80 amino-
terminal residues. In the amino terminal part of the 
protein a NAC/DEFCAP/CARD7 homology domain is 
present. 
Expression 
Normal tissue: wide and differential expression at 
mRNA level in tissues; present in heart, brain, lung, 
muscle, spleen, ovary; high in kidney, testis and spinal 
cord; absent in liver. 
Cancer: the CARD8 (48 kDa) protein is differentially 
expressed in cancer. High levels of CARD8 expression 
were found in tumor cell lines, including breast, 
prostate, ovarian and colon cancer cells as well as high 
expression in non-small cell lung cancer (NSCLC) cells 
and with hardly detectable expression in normal lung, 
in contrast to a lack of expression in small-cell lung 
cancer cell lines. In tumor specimens from patients 
CARD8 expression has been demonstrated in colon 
cancer and non-small cell lung cancer. 
 
 
Schematic representation of two CARD8 variants. The CARD domain, the NAC/DEFCAP/CARD7 homology domain, and the amino-
terminal residues that differ between the isoforms are indicated. 
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The 54-kDa CARD8 isoform has a different expression 
profile when compared to TUCAN/CARD8-48. For 
example a number of breast cancer cell lines do not 
express TUCAN/CARD8-54, although some of them 
express TUCAN/CARD8-48. Expression also varies 
widely among different tumor cell lines with high 
levels in colon cancer cells. 
Localisation 
In MCF-7 cells overexpressed CARD8 localized to 
both the cytoplasmic and nuclear compartment. In 
specimens derived from colon cancer cells a 
predominant cytoplasmic expression was found, 
whereas in NSCLC tumor samples CARD8 was either 
exclusively nuclear or cytoplasmic or present in both 
compartments. 
Function 
CARD8 belongs to the CARD family of proteins that 
play a role in apoptosis regulation and NF-kB signaling 
associated with the innate or adaptive immune 
response. For example the binding of CARDs present 
in caspase-9 and Apaf-1 mediate the assembly of the 
apoptosome in which caspase-9 is activated. CARD 
motifs have different binding selectivity towards each 
other and the presence of additional structural/ 
functional domains in the various CARD-containing 
proteins may also determine the choice of interaction 
partner. 
In literature there is some controversy on the function 
of CARD8. Some reports mention an apoptosis 
inhibitory function of CARD8 involving its CARD-
dependent binding to procaspase-9, whereas others did 
not find an association between CARD8 and caspase-9 
and instead found either pro-apoptotic activity of 
CARD8 and associations with the inflammatory 
caspase-1 or the regulatory subunit of IkB kinase 
(NEMO) thereby suppressing NF-kB activation. Also 
an interaction between the p53-responsive gene DRAL 
(FLH2) and CARD8 has been reported resulting in the 
suppression of NF-kB activation. Furthermore, 
TUCAN/CARD8-54 was found to inhibit 
chemotherapy-induced caspase-9 activation and Fas 
ligand-induced caspase-8 activation. Based mainly on 
its proposed anti-apoptotic activity CARD8 is 
considered as a possible therapeutic target for cancer. 
Homology 
CARD family proteins. 
Mutations 
Somatic 
Ten single nucleotide polymorphisms (SNPs) across 
TUCAN/CARD8 have been identified in healthy 
persons and patients suffering from inflammatory bowl 
disease. 
 
Implicated in 
Colon cancer 
Prognosis 
TUCAN/CARD8 expression has been analyzed by 
immunohistochemistry in paraffin-embedded colon 
cancer specimens (N=102) derived from patients with 
clinical stage II that were surgically treated. 
TUCAN/CARD8 staining was stronger in colon cancer 
cells when compared to normal cells in 64% of the 102 
specimens examined. Scoring staining intensity 
revealed a significant correlation between high 
TUCAN/CARD8 expression in tumor cells and shorter 
patient survival. 
Non-small cell lung cancer (NSCLC) 
Prognosis 
The expression of TUCAN/CARD8 has been 
determined by immunohistochemistry in tumor 
specimens derived from NSCLC patients (N=49, stage 
III and IV) that received neoadjuvant or palliative 
chemotherapy. TUCAN/CARD8 expression was 
detected in 69% of the samples, showing exclusively 
cytoplasmic (27%) or nuclear (11%) staining, or in 
both compartments (31%). No correlation between 
response to chemotherapy or expression/ localization 
was found, although, cytoplasm-only staining NSCLC 
samples predicted shorter survival, suggesting a 
possible prognostic value. 
Inflammatory bowel disease (IBD) 
Disease 
Crohn’s disease and ulcerative colitis. 
Prognosis 
Patients with IBD (Crohn’s disease (CD) and ulcerative 
colitis) and healthy individuals were genotyped for 
SNP. A significant association between a TUCAN SNP 
and CD was found. However, in other reports this 
association was not confirmed, rejecting 
TUCAN/CARD8 as a possible susceptibility gene for 
IBD. 
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